Derivatives of macrocyclic N-aryl-tricyclopyrimidine-2-amine polyethers as inhibitors of FTL3 and JAK
申请人:PIERRE FABRE MEDICAMENT
公开号:US10323043B2
公开(公告)日:2019-06-18
The present invention relates to a compound with the following formula (I): (I) or a salt and/or a pharmaceutically acceptable solvate thereof, in particular for use as a drug, in particular in the treatment of cancer, as well as to the pharmaceutical compositions that contain same and to the methods for preparing same.
DERIVES DE N-ARYL-TRICYCLOPYRIMIDINE-2-AMINE POLYETHERS MACROCYCLIQUES COMME INHIBITEURS DE LA FTL3 ET JAK
申请人:Pierre Fabre Médicament
公开号:EP3189061A1
公开(公告)日:2017-07-12
[EN] DERIVATIVES OF MACROCYCLIC N-ARYL-TRICYCLOPYRIMIDINE-2-AMINE POLYETHERS AS INHIBITORS OF FTL3 AND JAK<br/>[FR] DERIVES DE N-ARYL-TRICYCLOPYRIMIDINE-2-AMINE POLYETHERS MACROCYCLIQUES COMME INHIBITEURS DE LA FTL3 ET JAK
申请人:PF MEDICAMENT
公开号:WO2016034637A1
公开(公告)日:2016-03-10
La présente invention concerne un composé de formule (I) suivante : (I) ou un sel et/ou un solvate pharmaceutiquement acceptable de celui-ci, notamment pour son utilisation comme médicament, notamment dans le traitement du cancer, ainsi que les compositions pharmaceutiques le contenant et ses procédés de préparation.
DERIVATIVES OF MACROCYCLIC N-ARYL-TRICYCLOPYRIMIDINE-2-AMINE POLYETHERS AS INHIBITORS OF FTL3 AND JAK
申请人:PIERRE FABRE MEDICAMENT
公开号:US20170283432A1
公开(公告)日:2017-10-05
The present invention relates to a compound with the following formula (I): (I) or a salt and/or a pharmaceutically acceptable solvate thereof, in particular for use as a drug, in particular in the treatment of cancer, as well as to the pharmaceutical compositions that contain same and to the methods for preparing same.